★★★★★ 5
No pimples fast
Do what it said. Love on my skin
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 13, 2026
surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
Modeling potential costeffectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity Hoog 2025 Obesity Wiley Online Library Online Weight Loss Covered by UnitedHealthcare Shapely Tirzepatide Shows Superior Weight Loss Over Semaglutide in Phase 3 Trial Drug Topics Ozempic, Mounjaro: 6 'Hidden' Side Effects of GLP 1 Weight Loss Drugs Bacteriostatic Water Suppliers: Sterile Water, Syringes & More Bacteriostaticwater.com
Quick Dispatch:
Your surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants ships.
Need Help?
Questions about surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surmount-1 tirzepatide non-diabetic obesity trial SURMOUNT-1 (NEJM 2022) tested tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity and achieved up to 20.9% mean weight loss at the highest dose. 57% of participants in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
20.76
Tirzepatide vs semaglutide: A new battle in obesity treatment
23.56
How Did Diabetes Medications Become Weight Loss Meds? Beyond Journal Club on SURMOUNT-1 Trial – Core IM Podcast
23.41
SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients
29.12
Tirzepatide and the 10‐year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three‐year SURMOUNT‐1 trial - Hankosky
20.85
SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes
27.77
Tirzepatide lowers body weight for adults with obesity, regardless of disease duration
26.31
4.3 ★★★★★
Based on 1335 reviews
Sort
Product Reviews
★★★★★ 5
Best pimple patches for calming irritation!
These are my FAVORITE pimple patches. They effectively absorb any extra moisture or gunk coming from my pimples, and the centella in them helps relieve irritation. These have thinner edges, which helps them adhere well to your face, and they stay put all day when I wear them out, or all night when I sleep with them on. I have a cat who likes to smack my face with his all night long and they stay on through his barrage.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 28, 2025
★★★★★ 5
Great product for sensitive skin
These are gentle I really like them! Moisturizing is the having secret to treating blemishes. I highly recommend them and I would buy it again.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 21, 2026
★★★★★ 5
Barely noticeable
I like that these are almost completely invisible on the skin instead of like other patches where they are clear to see
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 19, 2026
★★★★★ 5
Best acne spot patches!
The best ace patches! I first bought them on a trip to Japan, and was using them sparingly until I ran out. They came fast and are about the same price as in Japan. Would absolutely recommend!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 7, 2025
recommand products
Compounded versions of weight loss drugs restricted, leaving some patients in a bind
28.88
Hims & Hers to offer generic semaglutide drugs in Canada
29.09
FDA says 'no clinical need' for compounded weight loss drugs
20.03
Legal pressures mount for Hims & Hers over GLP-1 sales
20.40
Hims Semaglutide (2026): FDA Warnings, Costs & Safety
27.35